Skip to content
MarketScale
‹ Back to IndustriesHealthcare

THE DUCTING KIT TAKES POWER BREEZER’S COOLING POWER EVEN FURTHER

In years past, employee comfort was not a top priority for business owners. Depending on the field, poor air quality and sweltering temperatures were just part of the job. But thanks to modern technology and some hard-won legal battles, employers today are compelled by state laws and federal OSHA guidelines to keep workplace climates at a safe…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

In years past, employee comfort was not a top priority for business owners. Depending on the field, poor air quality and sweltering temperatures were just part of the job. But thanks to modern technology and some hard-won legal battles, employers today are compelled by state laws and federal OSHA guidelines to keep workplace climates at a safe and comfortable temperature. However, proprietors should not consider employee comfort simply a legal mandate. Both air health and comfortable temperatures impact overall morale and productivity, making these environmental factors essential to positive bottom lines. 

This is where Breezer Mobile Cooling comes in. Our rugged, portable Power Breezer cooling unit is the most adaptable, cost-effective air conditioning alternative available. It combines jet engine science, water atomizing technology, and fluid dynamics to cool spaces up to 3,000 sq. ft. With the versatile ducting kit, facilities can unlock even more of their Power Breezer’s usability. Each kit comes with 10’ of collapsible 20” wide ducting. This allows facilities to cool larger areas by funneling cold air into tight spaces that were previously difficult to cool; e.g. underneath cars in a mechanic shop. The ability to varyingly direct air ensures that no matter the job or workspace, employees stay cool.

The portable, versatile Power Breezer and ducting kit from Breezer Mobile Cooling keep facilities compliant and comfortable, increasing overall efficiency while improving employee satisfaction. To learn more about how our ducting kit can keep workplaces safe, productive, and in compliance, check out the Power Breezer specifications or call 844-233-5673.

Read more at http://powerbreezer.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512